# CorPath® GRX Neuro Study

Study · id `cardio:ct-nct04236856` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04236856](<https://clinicaltrials.gov/study/NCT04236856>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04236856

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT04236856. Allocation not applicable; no masking; primary purpose treatment. Start 2020-08-21 (actual); primary completion 2022-04-23 (actual). Results posted on 2025-03-06.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT04236856, source copy `cardio:ctgov-nct04236856-2025-03-06`, retrieved 2026-11-18)
- Started: 2020-08-21 (actual) (ClinicalTrials.gov record NCT04236856, source copy `cardio:ctgov-nct04236856-2025-03-06`, retrieved 2026-11-18)
- Primary completion: 2022-04-23 (actual) (ClinicalTrials.gov record NCT04236856, source copy `cardio:ctgov-nct04236856-2025-03-06`, retrieved 2026-11-18)
- Completion: 2022-10-12 (actual) (ClinicalTrials.gov record NCT04236856, source copy `cardio:ctgov-nct04236856-2025-03-06`, retrieved 2026-11-18)
- Results first posted: 2025-03-06 (ClinicalTrials.gov record NCT04236856, source copy `cardio:ctgov-nct04236856-2025-03-06`, retrieved 2026-11-18)
- Countries: Australia; Austria; Canada; France; Spain; Switzerland (ClinicalTrials.gov record NCT04236856, source copy `cardio:ctgov-nct04236856-2025-03-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04236856-2025-03-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: CorPath® GRX Neuro Study
- Condition: Intracranial Aneurysm
- Condition: Subarachnoid Hemorrhage
- Condition: Headache
- Intervention (Device): Robotic Endovascular Procedure
- Lead sponsor: Siemens Healthineers Endovascular Robotics, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)

## Provenance

Content hash: e3ba381022c4968b2ed11e6f95c5033d1f3856dc1c82e8e83e395e5331b62415
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
